Healthcare provider profile · identity verified

Eric Norman Silbiger, D.O.

Family Practice · TORRANCE, CA · NPI 1457327694

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	549	172
Lisinopril	Lisinopril	368	115
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	325	48
Amlodipine Besylate	Amlodipine Besylate	321	101
Metformin Hcl	Metformin Hcl	245	73
Simvastatin	Simvastatin	226	67
Losartan Potassium	Losartan Potassium	217	64
Levothyroxine Sodium	Levothyroxine Sodium	208	67
Hydrochlorothiazide	Hydrochlorothiazide	204	61
Metoprolol Succinate	Metoprolol Succinate	203	71
Tamsulosin Hcl	Tamsulosin Hcl	184	52
Alprazolam	Alprazolam	168	29
Valsartan	Valsartan	156	43
Omeprazole	Omeprazole	147	60
Albuterol Sulfate Hfa	Albuterol Sulfate	131	49
Gabapentin	Gabapentin	117	35
Naproxen	Naproxen	112	45
Rosuvastatin Calcium	Rosuvastatin Calcium	112	39
Furosemide	Furosemide	109	38
Ibuprofen	Ibuprofen	106	32
Atenolol	Atenolol	105	30
Tramadol Hcl	Tramadol Hcl	102	29
Fluticasone Propionate	Fluticasone Propionate	91	36
Pravastatin Sodium	Pravastatin Sodium	91	29
Metoprolol Tartrate	Metoprolol Tartrate	82	24
Sertraline Hcl	Sertraline Hcl	78	23
Pioglitazone Hcl	Pioglitazone Hcl	76	26
Escitalopram Oxalate	Escitalopram Oxalate	75	21
Zolpidem Tartrate	Zolpidem Tartrate	74	20
Hydralazine Hcl	Hydralazine Hcl	73	22
Azithromycin	Azithromycin	72	54
Jardiance	Empagliflozin	72	21
Eliquis	Apixaban	70	26
Pregabalin	Pregabalin	70	26
Pantoprazole Sodium	Pantoprazole Sodium	66	27
Famotidine	Famotidine	65	26
Lovastatin	Lovastatin	61	15
Lorazepam	Lorazepam	58	17
Clopidogrel	Clopidogrel Bisulfate	57	17
Metformin Hcl Er	Metformin Hcl	56	23
Carvedilol	Carvedilol	55	19
Benazepril Hcl	Benazepril Hcl	52	15
Finasteride	Finasteride	52	15
Diazepam	Diazepam	51	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	50	13
Trazodone Hcl	Trazodone Hcl	50	18
Sildenafil Citrate	Sildenafil Citrate	48	12
Triamcinolone Acetonide	Triamcinolone Acetonide	47	25
Montelukast Sodium	Montelukast Sodium	46	15
Alendronate Sodium	Alendronate Sodium	44	15
Allopurinol	Allopurinol	42	15
Ezetimibe	Ezetimibe	42	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	14
Amoxicillin	Amoxicillin	39	24
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Ketoconazole	Ketoconazole	37	21
Clonazepam	Clonazepam	36	suppressed
Mirtazapine	Mirtazapine	36	11
Potassium Chloride	Potassium Chloride	36	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	11
Minoxidil	Minoxidil	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Morphine Sulfate Er	Morphine Sulfate	33	suppressed
Nifedipine Er	Nifedipine	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Glipizide Er	Glipizide	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Glipizide	Glipizide	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Prednisone	Prednisone	29	19
Meclizine Hcl	Meclizine Hcl	28	13
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Carisoprodol	Carisoprodol	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	21
Doxycycline Hyclate	Doxycycline Hyclate	22	19
Lidocaine	Lidocaine	22	suppressed
Ozempic	Semaglutide	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	16
Hydrocortisone	Hydrocortisone	21	12
Metronidazole	Metronidazole	20	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Etodolac	Etodolac	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	11	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error